Prostate Cancer Therapeutics Drugs Market 2028 By Drug Class, Distribution Channel | The Insight Partners

Prostate Cancer Therapeutics Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Report Code: TIPRE00021696 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET INTRODUCTION

Prostate cancer is cancer that occurs in the prostate and is the most common type of cancer. These cancers grow slowly and are confined to the prostate gland, where they may cause serious harm. Slow-growing prostate cancer may need minimal or even no treatment; however, other types are aggressive and can spread quickly.

MARKET DYNAMICS

Rising preferences of healthy living will increase geriatric population, awareness among people regarding prostate cancer along with technological advancement in screening and diagnostic tests are the major factors for market growth. Moreover, limited number of players and increasing pharmaceutical expenditure will create further opportunity for market's growth.

MARKET SCOPE

The "Prostate Cancer Therapeutics Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Prostate cancer therapeutics drugs market with detailed market segmentation by drug class and distribution channel. The prostate cancer therapeutics drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Prostate cancer therapeutics drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The prostate cancer therapeutics drugs market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is segmented as hormonal therapy, chemotherapy, immunotherapy, and targeted therapy. Based on distribution channel, the market is segmented as hospital pharmacies, retail pharmacies, and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Prostate cancer therapeutics drugs market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Prostate cancer therapeutics drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Prostate cancer therapeutics drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Prostate cancer therapeutics drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Prostate cancer therapeutics drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Prostate cancer therapeutics drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for Prostate cancer therapeutics drugs in the global market. Below mentioned is the list of few companies engaged in the Prostate cancer therapeutics drugs market.

The report also includes the profiles of key players in Prostate cancer therapeutics drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and drug class and distribution channel s offered, financial information of last 3 years, key development in past five years.

  •   JOHNSON AND JOHNSON
  •   ASTELLA, INC.
  •   SANOFI
  •   IPSEN
  •   BAYER AG
  •   ASTRAZENECA
  •   VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION)
  •   TOLMAR INC
  •   ENDO PHARMACEUTICALS
  •   ABBVIE, INC.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prostate Cancer Therapeutics Drugs Market - By Drug Class
1.3.2 Prostate Cancer Therapeutics Drugs Market - By Distribution Channel
1.3.3 Prostate Cancer Therapeutics Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PROSTATE CANCER THERAPEUTICS DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PROSTATE CANCER THERAPEUTICS DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PROSTATE CANCER THERAPEUTICS DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. PROSTATE CANCER THERAPEUTICS DRUGS - GLOBAL MARKET OVERVIEW
6.2. PROSTATE CANCER THERAPEUTICS DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PROSTATE CANCER THERAPEUTICS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. HORMONAL THERAPY
7.3.1. Overview
7.3.2. Hormonal Therapy Market Forecast and Analysis
7.3.3. Zytiga Market
7.3.3.1. Overview
7.3.3.2. Zytiga Market Forecast and Analysis
7.3.4. Gonax Market
7.3.4.1. Overview
7.3.4.2. Gonax Market Forecast and Analysis
7.3.5. Lupron Market
7.3.5.1. Overview
7.3.5.2. Lupron Market Forecast and Analysis
7.3.6. Zoladex Market
7.3.6.1. Overview
7.3.6.2. Zoladex Market Forecast and Analysis
7.3.7. Decapeptyl Market
7.3.7.1. Overview
7.3.7.2. Decapeptyl Market Forecast and Analysis
7.3.8. Eligard Market
7.3.8.1. Overview
7.3.8.2. Eligard Market Forecast and Analysis
7.3.9. Vantas Market
7.3.9.1. Overview
7.3.9.2. Vantas Market Forecast and Analysis
7.3.10. Casodex Market
7.3.10.1. Overview
7.3.10.2. Casodex Market Forecast and Analysis
7.3.11. Others Market
7.3.11.1. Overview
7.3.11.2. Others Market Forecast and Analysis
7.4. CHEMOTHERAPY
7.4.1. Overview
7.4.2. Chemotherapy Market Forecast and Analysis
7.4.3. Taxotere Market
7.4.3.1. Overview
7.4.3.2. Taxotere Market Forecast and Analysis
7.4.4. Jevtana Market
7.4.4.1. Overview
7.4.4.2. Jevtana Market Forecast and Analysis
7.5. IMMUNOTHERAPY
7.5.1. Overview
7.5.2. Immunotherapy Market Forecast and Analysis
7.5.3. Provenge Market
7.5.3.1. Overview
7.5.3.2. Provenge Market Forecast and Analysis
7.6. TARGETED THERAPY
7.6.1. Overview
7.6.2. Targeted Therapy Market Forecast and Analysis
7.6.3. Xofigo Market
7.6.3.1. Overview
7.6.3.2. Xofigo Market Forecast and Analysis
8. PROSTATE CANCER THERAPEUTICS DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. ONLINE PHARMACIES
8.5.1. Overview
8.5.2. Online Pharmacies Market Forecast and Analysis
9. PROSTATE CANCER THERAPEUTICS DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Prostate Cancer Therapeutics Drugs Market Overview
9.1.2 North America Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis
9.1.3 North America Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Drug Class
9.1.4 North America Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Prostate Cancer Therapeutics Drugs Market
9.1.5.1.1 United States Prostate Cancer Therapeutics Drugs Market by Drug Class
9.1.5.1.2 United States Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.1.5.2 Canada Prostate Cancer Therapeutics Drugs Market
9.1.5.2.1 Canada Prostate Cancer Therapeutics Drugs Market by Drug Class
9.1.5.2.2 Canada Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.1.5.3 Mexico Prostate Cancer Therapeutics Drugs Market
9.1.5.3.1 Mexico Prostate Cancer Therapeutics Drugs Market by Drug Class
9.1.5.3.2 Mexico Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Prostate Cancer Therapeutics Drugs Market Overview
9.2.2 Europe Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis
9.2.3 Europe Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Prostate Cancer Therapeutics Drugs Market
9.2.5.1.1 Germany Prostate Cancer Therapeutics Drugs Market by Drug Class
9.2.5.1.2 Germany Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.2.5.2 France Prostate Cancer Therapeutics Drugs Market
9.2.5.2.1 France Prostate Cancer Therapeutics Drugs Market by Drug Class
9.2.5.2.2 France Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.2.5.3 Italy Prostate Cancer Therapeutics Drugs Market
9.2.5.3.1 Italy Prostate Cancer Therapeutics Drugs Market by Drug Class
9.2.5.3.2 Italy Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.2.5.4 Spain Prostate Cancer Therapeutics Drugs Market
9.2.5.4.1 Spain Prostate Cancer Therapeutics Drugs Market by Drug Class
9.2.5.4.2 Spain Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.2.5.5 United Kingdom Prostate Cancer Therapeutics Drugs Market
9.2.5.5.1 United Kingdom Prostate Cancer Therapeutics Drugs Market by Drug Class
9.2.5.5.2 United Kingdom Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.2.5.6 Rest of Europe Prostate Cancer Therapeutics Drugs Market
9.2.5.6.1 Rest of Europe Prostate Cancer Therapeutics Drugs Market by Drug Class
9.2.5.6.2 Rest of Europe Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Prostate Cancer Therapeutics Drugs Market Overview
9.3.2 Asia-Pacific Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Prostate Cancer Therapeutics Drugs Market
9.3.5.1.1 Australia Prostate Cancer Therapeutics Drugs Market by Drug Class
9.3.5.1.2 Australia Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.3.5.2 China Prostate Cancer Therapeutics Drugs Market
9.3.5.2.1 China Prostate Cancer Therapeutics Drugs Market by Drug Class
9.3.5.2.2 China Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.3.5.3 India Prostate Cancer Therapeutics Drugs Market
9.3.5.3.1 India Prostate Cancer Therapeutics Drugs Market by Drug Class
9.3.5.3.2 India Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.3.5.4 Japan Prostate Cancer Therapeutics Drugs Market
9.3.5.4.1 Japan Prostate Cancer Therapeutics Drugs Market by Drug Class
9.3.5.4.2 Japan Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.3.5.5 South Korea Prostate Cancer Therapeutics Drugs Market
9.3.5.5.1 South Korea Prostate Cancer Therapeutics Drugs Market by Drug Class
9.3.5.5.2 South Korea Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Prostate Cancer Therapeutics Drugs Market
9.3.5.6.1 Rest of Asia-Pacific Prostate Cancer Therapeutics Drugs Market by Drug Class
9.3.5.6.2 Rest of Asia-Pacific Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Overview
9.4.2 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Prostate Cancer Therapeutics Drugs Market
9.4.5.1.1 South Africa Prostate Cancer Therapeutics Drugs Market by Drug Class
9.4.5.1.2 South Africa Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.4.5.2 Saudi Arabia Prostate Cancer Therapeutics Drugs Market
9.4.5.2.1 Saudi Arabia Prostate Cancer Therapeutics Drugs Market by Drug Class
9.4.5.2.2 Saudi Arabia Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.4.5.3 U.A.E Prostate Cancer Therapeutics Drugs Market
9.4.5.3.1 U.A.E Prostate Cancer Therapeutics Drugs Market by Drug Class
9.4.5.3.2 U.A.E Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Prostate Cancer Therapeutics Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Prostate Cancer Therapeutics Drugs Market by Drug Class
9.4.5.4.2 Rest of Middle East and Africa Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Prostate Cancer Therapeutics Drugs Market Overview
9.5.2 South and Central America Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis
9.5.3 South and Central America Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Prostate Cancer Therapeutics Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Prostate Cancer Therapeutics Drugs Market
9.5.5.1.1 Brazil Prostate Cancer Therapeutics Drugs Market by Drug Class
9.5.5.1.2 Brazil Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.5.5.2 Argentina Prostate Cancer Therapeutics Drugs Market
9.5.5.2.1 Argentina Prostate Cancer Therapeutics Drugs Market by Drug Class
9.5.5.2.2 Argentina Prostate Cancer Therapeutics Drugs Market by Distribution Channel
9.5.5.3 Rest of South and Central America Prostate Cancer Therapeutics Drugs Market
9.5.5.3.1 Rest of South and Central America Prostate Cancer Therapeutics Drugs Market by Drug Class
9.5.5.3.2 Rest of South and Central America Prostate Cancer Therapeutics Drugs Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROSTATE CANCER THERAPEUTICS DRUGS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PROSTATE CANCER THERAPEUTICS DRUGS MARKET, KEY COMPANY PROFILES
12.1. JOHNSON AND JOHNSON
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ASTELLA, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SANOFI
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. IPSEN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BAYER AG
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION)
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TOLMAR INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ENDO PHARMACEUTICALS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ABBVIE, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. JOHNSON AND JOHNSON
2. ASTELLA, INC.
3. SANOFI
4. IPSEN
5. BAYER AG
6. ASTRAZENECA
7. VALEANT PHARMACEUTICALS NORTH AMERICA LLC (DENDREON CORPORATION)
8. TOLMAR INC
9. ENDO PHARMACEUTICALS
10. ABBVIE, INC.
11. BDR Pharma
12. CADILA HEALTHCARE
13. DR. REDDY'S LABORATORIES
14. PFIZER
15. ASTELLAS PHARMA
TIPRE00021696
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount